Mental Health
Anxiety, depression, ADHD, sleep, and evidence-based care.
Clear, practical health guides
Evidence-based content on metabolic health, aging & longevity, chronic disease, and everyday health decisions — no fluff, no sensationalism.
Browse All GuidesFeatured Guide Hubs
Curated topic hubs — rotates weekly
Brain Health
Stroke, TIA, dementia, and brain health prevention.
Metabolic Health
Weight, insulin resistance, GLP-1s, and cardiometabolic risk.
Aging & Longevity
Aging biology, lifespan heritability, and longevity debates.
Latest Posts
Why Scientists Thought Pancreatic Cancer Was 'Undruggable' — And What Changed
A new RAS-targeting drug called daraxonrasib has generated excitement in advanced pancreatic cancer. Here's why researchers believe it could mark an important step forward.
Could Ozempic and Similar Drugs Help Protect the Kidneys?
GLP-1 drugs are best known for diabetes and weight loss, but growing evidence suggests they may also help protect kidney function in some patients.
Ebola Spreads Slowly. So Why Is The World So Concerned?
The current Ebola outbreak has triggered global concern despite Ebola being far less contagious than COVID. Here's why health experts still take it so seriously.
Hantavirus on a Cruise Ship: What the 2026 Cluster Actually Means
A hantavirus cluster linked to a cruise voyage is generating headlines. Here is what the investigation means, why the public risk is low, and what anyone who travelled on the affected vessel should know.
AI for Clinicians Just Got Serious — But Patients Are Still on Their Own
OpenAI just launched ChatGPT for Clinicians. It’s powerful—but it highlights a bigger gap on the patient side.
Latest Guides
Recently updated health guides
Abdominal Aortic Aneurysm Screening: Who Should Be Tested and When
A plain-English guide to abdominal aortic aneurysm (AAA) screening — what an AAA is, why rupture is so dangerous, who should have an ultrasound, what results mean, and how surveillance and treatment decisions are made.
Cancer — Guide Hub
Cancer is a group of diseases where abnormal cells grow uncontrollably and may spread. Explore guides on bowel, breast, prostate, skin, cervical, and liver cancer.
Lung Cancer Screening: Low-Dose CT, Benefits, Risks, and Eligibility
A plain-English guide to lung cancer screening with low-dose CT — who qualifies, what pack-years means, what the scan involves, the balance of benefits and risks, and how Australian and international guidelines approach this intervention.
Bone Density Testing (DEXA): Who Should Be Screened and When
A practical patient guide to bone density scanning — how DEXA works, how to interpret T-scores, who should be screened, what osteoporosis and osteopenia mean, and what to do after your results.
KRAS Mutations Explained: Why Some Cancer Targets Are Hard to Treat
A clear explanation of KRAS mutations — what KRAS is, how mutations lock cell-signalling on, why KRAS was historically undruggable, how the science shifted, which cancers are affected, and where targeted therapy stands now.
Pancreatic Cancer: Symptoms, Diagnosis, and Treatment
A patient-focused guide to pancreatic cancer — covering symptoms, why diagnosis is often delayed, how it is staged, surgery, chemotherapy, targeted therapy, biomarker testing, and what the evidence says about prognosis.
Precision Medicine in Cancer: Biomarkers, Targeted Therapy, and Genetic Testing
A clear guide to precision oncology — how tumours are profiled, what biomarkers mean, how targeted therapy differs from chemotherapy and immunotherapy, what companion diagnostics are, and what the limits of the approach are.
PSA Screening: Benefits, Risks, and Shared Decision-Making
A balanced, evidence-based guide to PSA testing for prostate cancer — covering what the test measures, potential benefits, false positives, overdiagnosis, high-risk groups, and how to approach the decision with your clinician.